Device Trial Radar · NCT03635190
Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease
Last checked: Nov 20, 2026Latest source record: Nov 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
112
Actual
Start
Dec 17, 2018
Primary completion
Mar 24, 2021
Study completion Oct 13, 2021
Sponsor
- Lead sponsor
- Cardio Flow, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Libra Medical
- First posted
- Aug 17, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and effectiveness of the Cardio Flow FreedomFlow™ Orbital Circumferential Atherectomy System for atherosclerotic plaque removal and vessel compliance modification in de novo native target lesions in the peripheral vasculature of the lower extremities.
Conditions
- Peripheral Arterial Disease
Interventions
Orbital Circumferential AtherectomyDevice
Remove atherosclerotic plaque and modify vessel wall compliance within peripheral arterial vessels. The therapy is intended for patients who are acceptable candidates for percutaneous transluminal atherectomy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Technical SuccessTime frame: At the time of the index procedure, usually within one hour after starting the procedure
- Freedom From Major Adverse EventsTime frame: 30 days
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Orlando Heart and Vascular Institute
Altamonte Springs, Florida
Palm Vascular Center of Broward, LLC
Fort Lauderdale, Florida
Cardiovascular Research of North Florida, LLC
Gainesville, Florida
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.